Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (unaudited)

v3.22.2.2
Statements of Operations (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 1,612,552 $ 867,197 $ 3,208,391 $ 1,547,785
General and administrative 1,118,021 462,772 2,308,334 2,043,957
Total operating expenses 2,730,573 1,329,969 5,516,725 3,591,742
Loss from operations (2,730,573) (1,329,969) (5,516,725) (3,591,742)
Other income and expenses:        
Interest expense, net 0 1,823 0 44,958
Net loss $ (2,730,573) $ (1,331,792) $ (5,516,725) $ (3,636,700)
Net loss per share of common stock, basic and diluted $ (0.24) $ (0.70) $ (0.56) $ (1.90)
Weighted-average basic and diluted common units/shares 11,194,857 1,911,009 9,781,510 1,911,009